Pfizer heart pill to be standalone therapy

Jul 26, 2006

U.S.-based Pfizer Inc., the world's largest pharmaceutical company, says it has decided to sell a new heart treatment medication as a standalone pill.

Pfizer initially announced it would sell the new drug, torcetrapib, only in combination with Lipitor, the company's best-selling cholesterol treatment medication, The New York Times reported. That decision produced strong opposition from physicians.

Torcetrapib, still being tested in clinical trials, is at least 18 months from receiving federal approval. But initial trial results indicate the drug substantially raises the levels of so-called good cholesterol -- a novel approach to preventing heart attacks and strokes, the Times said.

If Pfizer had offered torcetrapib only in a combination pill, that would have forced patients taking other cholesterol-lowering statins -- such as Merck & Co. Inc.'s Zocor -- to switch to Lipitor to obtain torcetrapib's benefits.

If proven effective, industry observers say the drug could potentially garner several billion dollars annually in sales.

Copyright 2006 by United Press International

Explore further: Tips offered to docs, spouses for maintaining happy marriage

add to favorites email to friend print save as pdf

Related Stories

FDA adds heart warning to Pfizer anti-smoking pill

Jun 16, 2011

(AP) -- Federal health regulators are warning doctors and patients that Pfizer's anti-smoking drug Chantix may slightly increase the risk of heart attack and other cardiovascular problems.

Hormone-blocking drug reduces breast cancer risk

Jun 04, 2011

(AP) -- Millions of women at higher-than-usual risk of breast cancer have a new option for preventing the disease. Pfizer Inc.'s Aromasin cut the risk of developing breast cancer by more than half, without the side effects ...

UNICEF discloses vaccine prices for 1st time

May 29, 2011

UNICEF is for the first time publicizing what drugmakers charge it for vaccines, as the world's biggest buyer of lifesaving immunizations aims to spark price competition in the face of rising costs.

Recommended for you

Limit imaging scans for headache? Neurosurgeons raise concerns

5 minutes ago

Recent guidelines seeking to reduce the use of neuroimaging tests for patients with headaches run the risk of missing or delaying the diagnosis of brain tumors, according to a special article in the January issue of Neurosurgery, offici ...

Study links suicide risk with insomnia, alcohol use

15 minutes ago

A new study is the first to show that insomnia symptoms mediate the relationship between alcohol use and suicide risk, and that this mediation is moderated by gender. The study suggests that the targeted ...

Appeals court nixes NC abortion ultrasound law

29 minutes ago

A federal appeals court has struck down a North Carolina law requiring abortion providers to show and describe an ultrasound to the pregnant woman, even if she refuses to look or listen.

Ebola death toll passes 7,500

29 minutes ago

More than 7,500 people have now died from the Ebola virus, as the number of cases climbs towards 20,000, the World Health Organization said Monday.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.